Lab-Grown Human Immune System Model Uncovers Weakened Response in Cancer Patients

New Take on Immunotherapy Reinvigorates T Cells by Blocking Uptake of Energy-Sapping Cancer Byproducts

NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain

Tecovirimat was safe but did not reduce the time to lesion resolution or reduce pain among adults with mild to moderate clade II mpox and a low risk of severe disease in an international study.

Contact

Submit a Media Request

Contact the NIAID News & Science Writing Branch.

301-402-1663
niaidnews@niaid.nih.gov
All Media Contacts

Gene Editing Approach Paves the Way to First-in-Human Clinical Trial for Rare Genetic Disease

Media Type
Article
Publish or Event Date
Research Institution
Massachusetts General Hospital
Short Title
Gene Editing Approach Paves the Way to First-in-Human Clinical Trial for Rare Genetic Disease
Content Coordinator
Content Manager

Unique Immune Response in Lupus Paves Way for New Treatment

Eczema Prevention Research

Currently there is no clearly effective way to prevent eczema. Many studies have tested a variety of eczema prevention strategies in pregnant and breastfeeding women and in infants. These include emollients or moisturizers, probiotics, prebiotics, synbiotics, vitamin D supplementation, hydrolyzed baby formula, early introduction of egg or cow’s milk, dietary supplements during breastfeeding, dust mite avoidance, Bacillus Calmette-Guerin (BCG) vaccination, antimicrobials, anti-worm medications, and antibiotic avoidance. Of all these experimental interventions, only a few have led to a small or modest reduction in the risk for childhood eczema.

NIH Statement on World AIDS Day

Together with our partners, the National Institutes of Health (NIH) commemorates World AIDS Day and affirms our commitment to bolstering the extraordinary gains achieved in HIV science and to persevering until we end HIV-related illness and stigma. As we mark this observance, we celebrate the people who enable scientific progress, honor the loved ones and leaders we have lost, and reflect on the work that remains to ensure the health and life quality of all people affected by, and living with, HIV.

Contact

Submit a Media Request

Contact the NIAID News & Science Writing Branch.

301-402-1663
niaidnews@niaid.nih.gov
All Media Contacts

Reviving Immune Responsiveness after Tuberculosis

NIH Awards $7.5 Million to Ankur Singh for Pioneering Human Immune Organoid Research

Media Type
Article
Publish or Event Date
Research Institution
Georgia Tech
Short Title
NIH Awards $7.5 Million to Ankur Singh for Pioneering Human Immune Organoid Research
Content Coordinator
Content Manager

Rensselaer Researcher Receives $3 Million Grant To Explore Gut Health